Pasithea Therapeutics Corp (KTTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 0 | 0 | 15 | 0 |
| Cost of Goods | N/A | N/A | N/A | 17 | N/A |
| Gross Profit | N/A | N/A | N/A | -2 | N/A |
| Operating Expenses | 14,250 | 15,979 | 12,589 | 4,523 | 41 |
| Operating Income | -14,250 | -15,979 | -12,589 | -4,507 | -41 |
| Interest Expense | 0 | 0 | 0 | 1 | 0 |
| Other Income | 345 | 472 | 861 | 2,334 | 0 |
| Pre-tax Income | -13,905 | -15,508 | -11,728 | -2,174 | -41 |
| Net Income Continuous | -13,905 | -15,508 | -11,728 | -2,174 | -41 |
| Net Income Discontinuous | N/A | -454 | -2,209 | N/A | N/A |
| Net Income | $-13,905 | $-15,962 | $-13,937 | $-2,174 | $-41 |
| EPS Basic Total Ops | -12.69 | -13.01 | -11.03 | -4.20 | 0.00 |
| EPS Basic Continuous Ops | -12.69 | -12.64 | -9.29 | -4.18 | -0.11 |
| EPS Basic Discontinuous Ops | N/A | -0.37 | -1.74 | N/A | N/A |
| EPS Diluted Total Ops | -12.69 | -13.01 | -11.03 | -4.20 | 0.00 |
| EPS Diluted Continuous Ops | -12.69 | -12.64 | -9.29 | -4.18 | -0.11 |
| EPS Diluted Discontinuous Ops | N/A | -0.37 | -1.74 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -12.69 | -12.64 | N/A | N/A | N/A |
| EBITDA(a) | $-13,601 | $-15,331 | $-12,584 | $-4,506 | $-41 |